Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204227
Max Phase: Preclinical
Molecular Formula: C50H104N28O10
Molecular Weight: 1257.57
Associated Items:
ID: ALA5204227
Max Phase: Preclinical
Molecular Formula: C50H104N28O10
Molecular Weight: 1257.57
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCN(CCCNC(N)N)N[C@H](C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C50H104N28O10/c1-28(70-41(84)32(71-30(3)80)15-8-21-64-46(54)55)39(82)72-34(16-9-22-65-47(56)57)43(86)75-36(18-11-24-67-49(60)61)45(88)76-35(17-10-23-66-48(58)59)44(87)74-33(14-5-7-20-52)42(85)73-31(13-4-6-19-51)40(83)69-27-78(26-12-25-68-50(62)63)77-37(29(2)79)38(53)81/h28-29,31-37,50,68,77,79H,4-27,51-52,62-63H2,1-3H3,(H2,53,81)(H,69,83)(H,70,84)(H,71,80)(H,72,82)(H,73,85)(H,74,87)(H,75,86)(H,76,88)(H4,54,55,64)(H4,56,57,65)(H4,58,59,66)(H4,60,61,67)/t28-,29+,31-,32-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: CUOQPACNYWWUOF-XNRQVXKYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1257.57 | Molecular Weight (Monoisotopic): 1256.8490 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Osman EEA, Rehemtulla A, Neamati N.. (2022) Why All the Fury over Furin?, 65 (4.0): [PMID:34340303] [10.1021/acs.jmedchem.1c00518] |
Source(1):